GABRB2

GABRB2
Identifiers
AliasesGABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, ICEE2, gamma-aminobutyric acid type A receptor subunit beta2, DEE92
External IDsOMIM: 600232; MGI: 95620; HomoloGene: 7327; GeneCards: GABRB2; OMA:GABRB2 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

2561

14401

Ensembl

ENSG00000145864

ENSMUSG00000007653

UniProt

P47870

P63137

RefSeq (mRNA)

NM_000813
NM_021911
NM_001371727

NM_008070
NM_001347314
NM_001362646
NM_001362647
NM_001362649

RefSeq (protein)

NP_000804
NP_068711
NP_001358656

NP_001334243
NP_032096
NP_001349575
NP_001349576
NP_001349578

Location (UCSC)Chr 5: 161.29 – 161.55 MbChr 11: 42.31 – 42.52 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

The GABAA beta-2 subunit is a protein that in humans is encoded by the GABRB2 gene. It combines with other subunits to form the ionotropic GABAA receptors. GABA (γ-aminobutyric acid) system is the major inhibitory system in the brain, and its dominant GABAA receptor subtype is composed of α1, β2, and γ2 subunits with the stoichiometry of 2:2:1, which accounts for 43% of all GABAA receptors. Alternative splicing of the GABRB2 gene leads at least to four isoforms, viz. β2-long (β2L) and β2-short (β2S, β2S1, and β2S2). Alternatively spliced variants displayed similar but non-identical electrophysiological properties. GABRB2 is subjected to positive selection and known to be both an alternative splicing and a recombination hotspot; it is regulated via epigenetic regulation including imprinting and gene and promoter methylation GABRB2 has been associated with a number of neuropsychiatric disorders, and found to display altered expression in cancer.